StonvexLoading…
StonvexStonvexStonvexCore line items from ENOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.25B | $2.11B | $1.71B | $1.56B |
Operating Income | $-1.12B | $-775.72M | $-65.71M | $-71.18M |
Net Income | $-1.18B | $-825.49M | $-33.26M | $-13.29M |
EPS (Diluted) | $-20.75 | $-14.93 | $-0.61 | $-0.25 |
Total Assets | $3.83B | $4.72B | $4.51B | $4.27B |
Total Liabilities | $2.34B | $2.15B | $1.09B | $823.45M |
Cash & Equivalents | $36.39M | $48.17M | $36.19M | $24.30M |
Free Cash Flow OCF − CapEx | $19.92M | $-67.21M | $12.77M | $-161.31M |
Shares Outstanding | 57.19M | 55.88M | 54.60M | 54.23M |